Daewoong Co., Ltd.

KSE 003090.KS

Daewoong Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD 157.94 M

Daewoong Co., Ltd. Operating Cash Flow is USD 157.94 M for the year ending December 31, 2023, a 34.11% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Daewoong Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 117.77 M, a 5.66% change year over year.
Daewoong Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 111.47 M, a -16.47% change year over year.
Daewoong Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 133.45 M, a 11.77% change year over year.
Daewoong Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 119.40 M, a 194.30% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

KSE: 003090.KS

Daewoong Co., Ltd.

CEO	Mr. Yeong-Hwan Yoon
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	35-14, Jajanggongdan 4-gil
Employees	353
Sector	Healthcare
Industries Pharmaceuticals Drugstores & Retail Pharmacies Eyewear

Description

Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1961 and is headquartered in Seongnam-si, South Korea.

Key trends

Past 5 years